Advertisement

Index by author

September 01, 1992; Volume 262,Issue 3

A

  1. Ali, B

    1. Characteristics of a cytosolic arylacylamidase metabolizing thiacetazone.
      P Khanna, S Kaur, G G Sanwal and B Ali
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1225-1231;

  2. Andazola, J J

    1. Characterization and localization of leukotriene C4 receptors in bullfrog lung.
      M Chiono, J J Andazola, O A Torres and C A Herman
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1248-1255;

  3. Anders, M W

    1. L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine transport in rat liver canalicular membrane vesicles: potential reabsorption mechanisms for biliary metabolites of glutathione and its S-conjugates.
      T W Simmons, M W Anders and N Ballatori
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1182-1188;

  4. Asprodini, E K

    1. Epileptogenesis reduces the sensitivity of presynaptic gamma-aminobutyric acidB receptors on glutamatergic afferents in the amygdala.
      E K Asprodini, D G Rainnie and P Shinnick-Gallagher
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1011-1021;

  5. Aulakh, C S

    1. Functional subsensitivity of 5-hydroxytryptamine1C or alpha 2 adrenergic heteroreceptors mediating clonidine-induced growth hormone release in the Fawn-Hooded rat strain relative to the Wistar rat strain.
      C S Aulakh, J L Hill, K P Lesch and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1038-1043;

  6. Auta, J

    1. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR).
      E Romeo, J Auta, A P Kozikowski, D Ma, V Papadopoulos, G Puia, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 971-978;

  7. Azoulay-Dupuis, E

    1. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
      E Vallée, E Azoulay-Dupuis, J Bauchet and J J Pocidalo
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1203-1208;

  8. Azuma, M

    1. Inhibition by amiloride of ouabain-evoked catecholamine secretion from cultured adrenal chromaffin cells: evidence for its blocking action on interaction between ouabain and Na+/K(+)-pump.
      K Morita, M Azuma, S Hamano, M Oka and K Teraoka
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1209-1213;

B

  1. Ballatori, N

    1. L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine transport in rat liver canalicular membrane vesicles: potential reabsorption mechanisms for biliary metabolites of glutathione and its S-conjugates.
      T W Simmons, M W Anders and N Ballatori
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1182-1188;

  2. Bandettini, P A

    1. Pyrethroid insecticide-induced alterations in mammalian synaptic membrane potential.
      J T Eells, P A Bandettini, P A Holman and J M Propp
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1173-1181;

  3. Baron, B M

    1. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
      B M Baron, B L Harrison, I A McDonald, B S Meldrum, M G Palfreyman, F G Salituro, B W Siegel, A L Slone, J P Turner and H S White
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 947-956;

  4. Basbaum, A I

    1. Sympathoadrenal contribution to nicotinic and muscarinic modulation of bradykinin-induced plasma extravasation in the knee joint of the rat.
      F J Miao, N L Benowitz, A I Basbaum and J D Levine
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 889-895;

  5. Bauchet, J

    1. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
      E Vallée, E Azoulay-Dupuis, J Bauchet and J J Pocidalo
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1203-1208;

  6. Benowitz, N L

    1. Sympathoadrenal contribution to nicotinic and muscarinic modulation of bradykinin-induced plasma extravasation in the knee joint of the rat.
      F J Miao, N L Benowitz, A I Basbaum and J D Levine
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 889-895;

  7. Bjork, F A

    1. Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands.
      J A Keiser, F A Bjork, J C Hodges and D G Taylor
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1154-1160;

  8. Blaylock, B L

    1. Thymocyte injury after in vitro chemical exposure: potential mechanisms for thymic atrophy.
      C E Comment, B L Blaylock, D R Germolec, P L Pollock, Y Kouchi, H W Brown, G J Rosenthal and M I Luster
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1267-1273;

  9. Blumberg, P M

    1. Identification of alpha-1-acid glycoprotein (orosomucoid) as a major vanilloid binding protein in serum.
      A Szallasi, N E Lewin and P M Blumberg
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 883-888;

  10. Bobbitt, J L

    1. Evidence that phospholipase A2 (PLA2) inhibitors can selectively block PLA2-mediated contractions of guinea pig lung pleural strips.
      D W Snyder, C D Sommers, J L Bobbitt and E D Mihelich
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1147-1153;

  11. Bonetti, E P

    1. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
      F Jenck, J L Moreau, E P Bonetti, J R Martin and W E Haefely
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1121-1127;

  12. Branch, R A

    1. Cimetidine-carbaryl interaction in humans: evidence for an active metabolite of carbaryl.
      D G May, R J Naukam, J R Kambam and R A Branch
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1057-1061;

  13. Bril, A

    1. Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function.
      B Gout, J Jean and A Bril
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 987-994;

  14. Brown, H W

    1. Thymocyte injury after in vitro chemical exposure: potential mechanisms for thymic atrophy.
      C E Comment, B L Blaylock, D R Germolec, P L Pollock, Y Kouchi, H W Brown, G J Rosenthal and M I Luster
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1267-1273;

  15. Buckner, C K

    1. Nonadrenergic, noncholinergic contractile responses of the guinea pig hilar bronchus involve the preferential activation of tachykinin neurokinin2 receptors.
      L M Renzetti, A Shenvi and C K Buckner
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 957-963;

  16. Burke, T F

    1. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
      S D Comer, T F Burke, J W Lewis and J H Woods
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1051-1056;

  17. Byrd, L D

    1. Enhanced sensitivity to the behavioral effects of cocaine after chronic administration of D2-selective dopamine antagonists in the squirrel monkey.
      L L Howell and L D Byrd
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 907-915;

C

  1. Caldwell, R W

    1. Effect of transient vagal cold blockade upon reflex actions of a polar and nonpolar cardiac glycoside.
      R W Caldwell and W R Rebagay
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1022-1027;

  2. Cassis, L A

    1. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
      L A Cassis, P E Rippetoe, E E Soltis, D J Painter, R Fitz and M N Gillespie
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1168-1172;

  3. Cawley, G

    1. Dietary choline supplementation increases the density of nicotine binding sites in rat brain.
      J B Coutcher, G Cawley and L Wecker
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1128-1132;

  4. Charlesworth, E N

    1. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge.
      E N Charlesworth, W A Massey, A Kagey-Sobotka, P S Norman and L M Lichtenstein
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 964-970;

  5. Cheng, C C

    1. Identification of the mixed disulfide of glutathione and cysteinylglycine in bile: dependence on gamma-glutamyl transferase and responsiveness to oxidative stress.
      C Madhu, Z Gregus, C C Cheng and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 896-900;

  6. Cheng, P Y

    1. Central opioid modulation of breathing dynamics in the fetal lamb: effects of [D-Pen2,D-Pen5]-enkephalin and partial antagonism by naltrindole.
      P Y Cheng, D L Wu, J Decena, Y Cheng, S McCabe and H H Szeto
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1004-1010;

  7. Cheng, Y

    1. Central opioid modulation of breathing dynamics in the fetal lamb: effects of [D-Pen2,D-Pen5]-enkephalin and partial antagonism by naltrindole.
      P Y Cheng, D L Wu, J Decena, Y Cheng, S McCabe and H H Szeto
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1004-1010;

  8. Cherian, M G

    1. Shifts in the dose-effect relationship for the nephropathy induced by cadmium-metallothionein in rats after a reduction in renal mass.
      R K Zalups, R M Gelein and M G Cherian
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1256-1266;

  9. Chiba, K

    1. Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.
      D R Sohn, K Kobayashi, K Chiba, K H Lee, S G Shin and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1195-1202;

  10. Chiono, M

    1. Characterization and localization of leukotriene C4 receptors in bullfrog lung.
      M Chiono, J J Andazola, O A Torres and C A Herman
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1248-1255;

  11. Chiu, P J

    1. Phosphoramidon abolishes the increases in endothelin-1 release induced by ischemia-hypoxia in isolated perfused guinea pig lungs.
      S Vemulapalli, M Rivelli, P J Chiu, M del Prado and J A Hey
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1062-1069;

  12. Comer, S D

    1. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
      S D Comer, T F Burke, J W Lewis and J H Woods
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1051-1056;

  13. Comment, C E

    1. Thymocyte injury after in vitro chemical exposure: potential mechanisms for thymic atrophy.
      C E Comment, B L Blaylock, D R Germolec, P L Pollock, Y Kouchi, H W Brown, G J Rosenthal and M I Luster
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1267-1273;

  14. Costa, E

    1. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR).
      E Romeo, J Auta, A P Kozikowski, D Ma, V Papadopoulos, G Puia, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 971-978;

  15. Coutcher, J B

    1. Dietary choline supplementation increases the density of nicotine binding sites in rat brain.
      J B Coutcher, G Cawley and L Wecker
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1128-1132;

D

  1. Davis, M G

    1. Thrombin, but not thromboxane, stimulates megakaryocytic differentiation in human megakaryoblastic leukemia cells.
      G W Dorn and M G Davis
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1242-1247;

  2. Decena, J

    1. Central opioid modulation of breathing dynamics in the fetal lamb: effects of [D-Pen2,D-Pen5]-enkephalin and partial antagonism by naltrindole.
      P Y Cheng, D L Wu, J Decena, Y Cheng, S McCabe and H H Szeto
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1004-1010;

  3. del Prado, M

    1. Phosphoramidon abolishes the increases in endothelin-1 release induced by ischemia-hypoxia in isolated perfused guinea pig lungs.
      S Vemulapalli, M Rivelli, P J Chiu, M del Prado and J A Hey
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1062-1069;

  4. DeSouza, E B

    1. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
      B Levant, D E Grigoriadis and E B DeSouza
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 929-935;

  5. Dewey, W L

    1. Evidence that endogenous opioids mediate the antinociceptive effects of intrathecally administered calcium in mice.
      F L Smith and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 995-1003;

  6. DiBona, G F

    1. Effects of renal denervation on sodium balance and renal function during chronic furosemide administration in rats.
      J S Petersen and G F DiBona
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1103-1109;

  7. Dorn, G W

    1. Thrombin, but not thromboxane, stimulates megakaryocytic differentiation in human megakaryoblastic leukemia cells.
      G W Dorn and M G Davis
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1242-1247;

E

  1. Eells, J T

    1. Pyrethroid insecticide-induced alterations in mammalian synaptic membrane potential.
      J T Eells, P A Bandettini, P A Holman and J M Propp
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1173-1181;

  2. Eguchi, N

    1. Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats.
      N Eguchi, T Kaneko, Y Urade, H Hayashi and O Hayaishi
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1110-1120;

  3. Endoh, M

    1. Concentration- and time-dependence of phosphoinositide hydrolysis induced by endothelin-1 in relation to the positive inotropic effect in the rabbit ventricular myocardium.
      M Takanashi and M Endoh
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1189-1194;

F

  1. Falcone, R C

    1. Guinea pig gall bladder contains a single peptide leukotriene receptor which resembles that present in human conducting airway smooth muscle.
      R C Falcone and R D Krell
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1095-1102;

  2. Ferrier, G R

    1. Differential effects of glyburide on premature beats and ventricular tachycardia in an isolated tissue model of ischemia and reperfusion.
      J S Pasnani and G R Ferrier
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1076-1084;

  3. Fink, D W

    1. Differential effects of 6-hydroxydopamine-induced ablation of peripheral and central adrenergic axons on C-1300 murine neuroblastoma tumor growth and catecholamine concentration in the A/J mouse.
      D W Fink, P T Horn and B L Mirkin
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1070-1075;

  4. Fitz, R

    1. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
      L A Cassis, P E Rippetoe, E E Soltis, D J Painter, R Fitz and M N Gillespie
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1168-1172;

  5. Fuchs, B A

    1. Morphine suppresses primary humoral immune responses by a predominantly indirect mechanism.
      S B Pruett, Y C Han and B A Fuchs
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 923-928;

  6. Fung, H L

    1. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle.
      E A Kowaluk, P Seth and H L Fung
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 916-922;

G

  1. Gelein, R M

    1. Shifts in the dose-effect relationship for the nephropathy induced by cadmium-metallothionein in rats after a reduction in renal mass.
      R K Zalups, R M Gelein and M G Cherian
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1256-1266;

  2. Germolec, D R

    1. Thymocyte injury after in vitro chemical exposure: potential mechanisms for thymic atrophy.
      C E Comment, B L Blaylock, D R Germolec, P L Pollock, Y Kouchi, H W Brown, G J Rosenthal and M I Luster
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1267-1273;

  3. Gillespie, M N

    1. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
      L A Cassis, P E Rippetoe, E E Soltis, D J Painter, R Fitz and M N Gillespie
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1168-1172;

  4. Goldberg, S R

    1. Pathophysiological and pharmacological mechanisms of acute cocaine toxicity in conscious rats.
      S R Tella, G R Korupolu, C W Schindler and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 936-946;

  5. Gout, B

    1. Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function.
      B Gout, J Jean and A Bril
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 987-994;

  6. Gregus, Z

    1. Identification of the mixed disulfide of glutathione and cysteinylglycine in bile: dependence on gamma-glutamyl transferase and responsiveness to oxidative stress.
      C Madhu, Z Gregus, C C Cheng and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 896-900;

  7. Grigoriadis, D E

    1. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
      B Levant, D E Grigoriadis and E B DeSouza
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 929-935;

  8. Grover, G J

    1. Effect of the phospholipase A2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat hearts.
      C A Sargent, O Vesterqvist, J R McCullough, M L Ogletree and G J Grover
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1161-1167;

  9. Guidotti, A

    1. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR).
      E Romeo, J Auta, A P Kozikowski, D Ma, V Papadopoulos, G Puia, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 971-978;

H

  1. Haefely, W E

    1. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
      F Jenck, J L Moreau, E P Bonetti, J R Martin and W E Haefely
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1121-1127;

  2. Hamano, S

    1. Inhibition by amiloride of ouabain-evoked catecholamine secretion from cultured adrenal chromaffin cells: evidence for its blocking action on interaction between ouabain and Na+/K(+)-pump.
      K Morita, M Azuma, S Hamano, M Oka and K Teraoka
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1209-1213;

  3. Han, Y C

    1. Morphine suppresses primary humoral immune responses by a predominantly indirect mechanism.
      S B Pruett, Y C Han and B A Fuchs
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 923-928;

  4. Harrison, B L

    1. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
      B M Baron, B L Harrison, I A McDonald, B S Meldrum, M G Palfreyman, F G Salituro, B W Siegel, A L Slone, J P Turner and H S White
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 947-956;

  5. Hayaishi, O

    1. Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats.
      N Eguchi, T Kaneko, Y Urade, H Hayashi and O Hayaishi
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1110-1120;

  6. Hayashi, H

    1. Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats.
      N Eguchi, T Kaneko, Y Urade, H Hayashi and O Hayaishi
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1110-1120;

  7. Herman, C A

    1. Characterization and localization of leukotriene C4 receptors in bullfrog lung.
      M Chiono, J J Andazola, O A Torres and C A Herman
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1248-1255;

  8. Hey, J A

    1. Phosphoramidon abolishes the increases in endothelin-1 release induced by ischemia-hypoxia in isolated perfused guinea pig lungs.
      S Vemulapalli, M Rivelli, P J Chiu, M del Prado and J A Hey
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1062-1069;

  9. Hill, J L

    1. Functional subsensitivity of 5-hydroxytryptamine1C or alpha 2 adrenergic heteroreceptors mediating clonidine-induced growth hormone release in the Fawn-Hooded rat strain relative to the Wistar rat strain.
      C S Aulakh, J L Hill, K P Lesch and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1038-1043;

  10. Hodges, J C

    1. Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands.
      J A Keiser, F A Bjork, J C Hodges and D G Taylor
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1154-1160;

  11. Holman, P A

    1. Pyrethroid insecticide-induced alterations in mammalian synaptic membrane potential.
      J T Eells, P A Bandettini, P A Holman and J M Propp
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1173-1181;

  12. Horn, P T

    1. Differential effects of 6-hydroxydopamine-induced ablation of peripheral and central adrenergic axons on C-1300 murine neuroblastoma tumor growth and catecholamine concentration in the A/J mouse.
      D W Fink, P T Horn and B L Mirkin
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1070-1075;

  13. Hoshino, J

    1. Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance.
      R Igarashi, J Hoshino, M Takenaga, S Kawai, Y Morizawa, A Yasuda, M Otani and Y Mizushima
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1214-1219;

  14. Howell, L L

    1. Enhanced sensitivity to the behavioral effects of cocaine after chronic administration of D2-selective dopamine antagonists in the squirrel monkey.
      L L Howell and L D Byrd
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 907-915;

  15. Huidobro-Toro, J P

    1. [N-methyl-Tyr1,N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat.
      S P Salas, J S Roblero, L F López, S Tachibana and J P Huidobro-Toro
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 979-986;

I

  1. Igarashi, R

    1. Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance.
      R Igarashi, J Hoshino, M Takenaga, S Kawai, Y Morizawa, A Yasuda, M Otani and Y Mizushima
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1214-1219;

  2. Ishizaki, T

    1. Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.
      D R Sohn, K Kobayashi, K Chiba, K H Lee, S G Shin and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1195-1202;

J

  1. Jean, J

    1. Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function.
      B Gout, J Jean and A Bril
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 987-994;

  2. Jenck, F

    1. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
      F Jenck, J L Moreau, E P Bonetti, J R Martin and W E Haefely
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1121-1127;

K

  1. Kagey-Sobotka, A

    1. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge.
      E N Charlesworth, W A Massey, A Kagey-Sobotka, P S Norman and L M Lichtenstein
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 964-970;

  2. Kambam, J R

    1. Cimetidine-carbaryl interaction in humans: evidence for an active metabolite of carbaryl.
      D G May, R J Naukam, J R Kambam and R A Branch
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1057-1061;

  3. Kaneko, T

    1. Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats.
      N Eguchi, T Kaneko, Y Urade, H Hayashi and O Hayaishi
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1110-1120;

  4. Kaur, S

    1. Characteristics of a cytosolic arylacylamidase metabolizing thiacetazone.
      P Khanna, S Kaur, G G Sanwal and B Ali
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1225-1231;

  5. Kawai, S

    1. Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance.
      R Igarashi, J Hoshino, M Takenaga, S Kawai, Y Morizawa, A Yasuda, M Otani and Y Mizushima
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1214-1219;

  6. Keiser, J A

    1. Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands.
      J A Keiser, F A Bjork, J C Hodges and D G Taylor
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1154-1160;

  7. Khanna, P

    1. Characteristics of a cytosolic arylacylamidase metabolizing thiacetazone.
      P Khanna, S Kaur, G G Sanwal and B Ali
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1225-1231;

  8. Kinney, G G

    1. Effect of prior sensitization of stereotypy on the development of tolerance to amphetamine-induced hypophagia.
      D L Wolgin and G G Kinney
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1232-1241;

  9. Klaassen, C D

    1. Identification of the mixed disulfide of glutathione and cysteinylglycine in bile: dependence on gamma-glutamyl transferase and responsiveness to oxidative stress.
      C Madhu, Z Gregus, C C Cheng and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 896-900;

  10. Kobayashi, K

    1. Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.
      D R Sohn, K Kobayashi, K Chiba, K H Lee, S G Shin and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1195-1202;

  11. Korupolu, G R

    1. Pathophysiological and pharmacological mechanisms of acute cocaine toxicity in conscious rats.
      S R Tella, G R Korupolu, C W Schindler and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 936-946;

  12. Kouchi, Y

    1. Thymocyte injury after in vitro chemical exposure: potential mechanisms for thymic atrophy.
      C E Comment, B L Blaylock, D R Germolec, P L Pollock, Y Kouchi, H W Brown, G J Rosenthal and M I Luster
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1267-1273;

  13. Kowaluk, E A

    1. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle.
      E A Kowaluk, P Seth and H L Fung
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 916-922;

  14. Kozikowski, A P

    1. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR).
      E Romeo, J Auta, A P Kozikowski, D Ma, V Papadopoulos, G Puia, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 971-978;

  15. Krell, R D

    1. Guinea pig gall bladder contains a single peptide leukotriene receptor which resembles that present in human conducting airway smooth muscle.
      R C Falcone and R D Krell
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1095-1102;

  16. Kuczenski, R

    1. Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine.
      R Kuczenski and D S Segal
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1085-1094;

L

  1. Lee, K H

    1. Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.
      D R Sohn, K Kobayashi, K Chiba, K H Lee, S G Shin and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1195-1202;

  2. Lelchuk, R

    1. Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells.
      R Lelchuk, M W Radomski, J F Martin and S Moncada
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1220-1224;

  3. Lesch, K P

    1. Functional subsensitivity of 5-hydroxytryptamine1C or alpha 2 adrenergic heteroreceptors mediating clonidine-induced growth hormone release in the Fawn-Hooded rat strain relative to the Wistar rat strain.
      C S Aulakh, J L Hill, K P Lesch and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1038-1043;

  4. Levant, B

    1. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
      B Levant, D E Grigoriadis and E B DeSouza
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 929-935;

  5. Levine, J D

    1. Sympathoadrenal contribution to nicotinic and muscarinic modulation of bradykinin-induced plasma extravasation in the knee joint of the rat.
      F J Miao, N L Benowitz, A I Basbaum and J D Levine
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 889-895;

  6. Lewin, N E

    1. Identification of alpha-1-acid glycoprotein (orosomucoid) as a major vanilloid binding protein in serum.
      A Szallasi, N E Lewin and P M Blumberg
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 883-888;

  7. Lewis, J W

    1. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
      S D Comer, T F Burke, J W Lewis and J H Woods
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1051-1056;

  8. Lichtenstein, L M

    1. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge.
      E N Charlesworth, W A Massey, A Kagey-Sobotka, P S Norman and L M Lichtenstein
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 964-970;

  9. López, L F

    1. [N-methyl-Tyr1,N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat.
      S P Salas, J S Roblero, L F López, S Tachibana and J P Huidobro-Toro
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 979-986;

  10. Louis, J C

    1. Receptor-mediated toxicity of norepinephrine on cultured catecholaminergic neurons of the rat brain stem.
      J C Louis, E Magal and S Varon
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1274-1283;

  11. Luster, M I

    1. Thymocyte injury after in vitro chemical exposure: potential mechanisms for thymic atrophy.
      C E Comment, B L Blaylock, D R Germolec, P L Pollock, Y Kouchi, H W Brown, G J Rosenthal and M I Luster
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1267-1273;

M

  1. Ma, D

    1. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR).
      E Romeo, J Auta, A P Kozikowski, D Ma, V Papadopoulos, G Puia, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 971-978;

  2. Mack, W M

    1. Discrimination of multiple binding sites for antagonists of the calcium release channel complex of skeletal and cardiac sarcoplasmic reticulum.
      W M Mack, I Zimányi and I N Pessah
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1028-1037;

  3. Madhu, C

    1. Identification of the mixed disulfide of glutathione and cysteinylglycine in bile: dependence on gamma-glutamyl transferase and responsiveness to oxidative stress.
      C Madhu, Z Gregus, C C Cheng and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 896-900;

  4. Magal, E

    1. Receptor-mediated toxicity of norepinephrine on cultured catecholaminergic neurons of the rat brain stem.
      J C Louis, E Magal and S Varon
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1274-1283;

  5. Martin, J F

    1. Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells.
      R Lelchuk, M W Radomski, J F Martin and S Moncada
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1220-1224;

  6. Martin, J R

    1. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
      F Jenck, J L Moreau, E P Bonetti, J R Martin and W E Haefely
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1121-1127;

  7. Massey, W A

    1. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge.
      E N Charlesworth, W A Massey, A Kagey-Sobotka, P S Norman and L M Lichtenstein
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 964-970;

  8. May, D G

    1. Cimetidine-carbaryl interaction in humans: evidence for an active metabolite of carbaryl.
      D G May, R J Naukam, J R Kambam and R A Branch
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1057-1061;

  9. McCabe, S

    1. Central opioid modulation of breathing dynamics in the fetal lamb: effects of [D-Pen2,D-Pen5]-enkephalin and partial antagonism by naltrindole.
      P Y Cheng, D L Wu, J Decena, Y Cheng, S McCabe and H H Szeto
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1004-1010;

  10. McCullough, J R

    1. Effect of the phospholipase A2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat hearts.
      C A Sargent, O Vesterqvist, J R McCullough, M L Ogletree and G J Grover
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1161-1167;

  11. McDonald, I A

    1. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
      B M Baron, B L Harrison, I A McDonald, B S Meldrum, M G Palfreyman, F G Salituro, B W Siegel, A L Slone, J P Turner and H S White
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 947-956;

  12. Meldrum, B S

    1. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
      B M Baron, B L Harrison, I A McDonald, B S Meldrum, M G Palfreyman, F G Salituro, B W Siegel, A L Slone, J P Turner and H S White
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 947-956;

  13. Miao, F J

    1. Sympathoadrenal contribution to nicotinic and muscarinic modulation of bradykinin-induced plasma extravasation in the knee joint of the rat.
      F J Miao, N L Benowitz, A I Basbaum and J D Levine
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 889-895;

  14. Mihelich, E D

    1. Evidence that phospholipase A2 (PLA2) inhibitors can selectively block PLA2-mediated contractions of guinea pig lung pleural strips.
      D W Snyder, C D Sommers, J L Bobbitt and E D Mihelich
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1147-1153;

  15. Mirkin, B L

    1. Differential effects of 6-hydroxydopamine-induced ablation of peripheral and central adrenergic axons on C-1300 murine neuroblastoma tumor growth and catecholamine concentration in the A/J mouse.
      D W Fink, P T Horn and B L Mirkin
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1070-1075;

  16. Mizushima, Y

    1. Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance.
      R Igarashi, J Hoshino, M Takenaga, S Kawai, Y Morizawa, A Yasuda, M Otani and Y Mizushima
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1214-1219;

  17. Moncada, S

    1. Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells.
      R Lelchuk, M W Radomski, J F Martin and S Moncada
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1220-1224;

  18. Moreau, J L

    1. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
      F Jenck, J L Moreau, E P Bonetti, J R Martin and W E Haefely
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1121-1127;

  19. Morita, K

    1. Inhibition by amiloride of ouabain-evoked catecholamine secretion from cultured adrenal chromaffin cells: evidence for its blocking action on interaction between ouabain and Na+/K(+)-pump.
      K Morita, M Azuma, S Hamano, M Oka and K Teraoka
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1209-1213;

  20. Morizawa, Y

    1. Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance.
      R Igarashi, J Hoshino, M Takenaga, S Kawai, Y Morizawa, A Yasuda, M Otani and Y Mizushima
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1214-1219;

  21. Murphy, D L

    1. Functional subsensitivity of 5-hydroxytryptamine1C or alpha 2 adrenergic heteroreceptors mediating clonidine-induced growth hormone release in the Fawn-Hooded rat strain relative to the Wistar rat strain.
      C S Aulakh, J L Hill, K P Lesch and D L Murphy
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1038-1043;

N

  1. Naukam, R J

    1. Cimetidine-carbaryl interaction in humans: evidence for an active metabolite of carbaryl.
      D G May, R J Naukam, J R Kambam and R A Branch
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1057-1061;

  2. Nickols, G A

    1. Purinergic vasoconstrictor component revealed by moderate cooling in the isolated mesenteric vasculature of Sprague-Dawley rats.
      R Yamamoto, K Takasaki and G A Nickols
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1133-1138;

  3. Norman, P S

    1. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge.
      E N Charlesworth, W A Massey, A Kagey-Sobotka, P S Norman and L M Lichtenstein
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 964-970;

O

  1. Ogletree, M L

    1. Effect of the phospholipase A2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat hearts.
      C A Sargent, O Vesterqvist, J R McCullough, M L Ogletree and G J Grover
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1161-1167;

  2. Oka, M

    1. Inhibition by amiloride of ouabain-evoked catecholamine secretion from cultured adrenal chromaffin cells: evidence for its blocking action on interaction between ouabain and Na+/K(+)-pump.
      K Morita, M Azuma, S Hamano, M Oka and K Teraoka
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1209-1213;

  3. Otani, M

    1. Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance.
      R Igarashi, J Hoshino, M Takenaga, S Kawai, Y Morizawa, A Yasuda, M Otani and Y Mizushima
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1214-1219;

P

  1. Painter, D J

    1. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
      L A Cassis, P E Rippetoe, E E Soltis, D J Painter, R Fitz and M N Gillespie
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1168-1172;

  2. Palfreyman, M G

    1. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
      B M Baron, B L Harrison, I A McDonald, B S Meldrum, M G Palfreyman, F G Salituro, B W Siegel, A L Slone, J P Turner and H S White
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 947-956;

  3. Papadopoulos, V

    1. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR).
      E Romeo, J Auta, A P Kozikowski, D Ma, V Papadopoulos, G Puia, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 971-978;

  4. Pasnani, J S

    1. Differential effects of glyburide on premature beats and ventricular tachycardia in an isolated tissue model of ischemia and reperfusion.
      J S Pasnani and G R Ferrier
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1076-1084;

  5. Pasternak, G W

    1. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.
      C G Pick, D Paul and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1044-1050;

  6. Paul, D

    1. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.
      C G Pick, D Paul and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1044-1050;

  7. Pessah, I N

    1. Discrimination of multiple binding sites for antagonists of the calcium release channel complex of skeletal and cardiac sarcoplasmic reticulum.
      W M Mack, I Zimányi and I N Pessah
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1028-1037;

  8. Petersen, J S

    1. Effects of renal denervation on sodium balance and renal function during chronic furosemide administration in rats.
      J S Petersen and G F DiBona
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1103-1109;

  9. Piascik, M T

    1. Effect of chlorethylclonidine on arterial blood pressure and heart rate in the conscious rat.
      M T Piascik, M S Sparks and T A Pruitt
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 901-906;

  10. Pick, C G

    1. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.
      C G Pick, D Paul and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1044-1050;

  11. Pocidalo, J J

    1. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
      E Vallée, E Azoulay-Dupuis, J Bauchet and J J Pocidalo
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1203-1208;

  12. Pollock, P L

    1. Thymocyte injury after in vitro chemical exposure: potential mechanisms for thymic atrophy.
      C E Comment, B L Blaylock, D R Germolec, P L Pollock, Y Kouchi, H W Brown, G J Rosenthal and M I Luster
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1267-1273;

  13. Propp, J M

    1. Pyrethroid insecticide-induced alterations in mammalian synaptic membrane potential.
      J T Eells, P A Bandettini, P A Holman and J M Propp
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1173-1181;

  14. Pruett, S B

    1. Morphine suppresses primary humoral immune responses by a predominantly indirect mechanism.
      S B Pruett, Y C Han and B A Fuchs
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 923-928;

  15. Pruitt, T A

    1. Effect of chlorethylclonidine on arterial blood pressure and heart rate in the conscious rat.
      M T Piascik, M S Sparks and T A Pruitt
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 901-906;

  16. Puia, G

    1. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR).
      E Romeo, J Auta, A P Kozikowski, D Ma, V Papadopoulos, G Puia, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 971-978;

R

  1. Radomski, M W

    1. Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells.
      R Lelchuk, M W Radomski, J F Martin and S Moncada
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1220-1224;

  2. Rainnie, D G

    1. Epileptogenesis reduces the sensitivity of presynaptic gamma-aminobutyric acidB receptors on glutamatergic afferents in the amygdala.
      E K Asprodini, D G Rainnie and P Shinnick-Gallagher
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1011-1021;

  3. Rebagay, W R

    1. Effect of transient vagal cold blockade upon reflex actions of a polar and nonpolar cardiac glycoside.
      R W Caldwell and W R Rebagay
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1022-1027;

  4. Renzetti, L M

    1. Nonadrenergic, noncholinergic contractile responses of the guinea pig hilar bronchus involve the preferential activation of tachykinin neurokinin2 receptors.
      L M Renzetti, A Shenvi and C K Buckner
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 957-963;

  5. Rippetoe, P E

    1. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
      L A Cassis, P E Rippetoe, E E Soltis, D J Painter, R Fitz and M N Gillespie
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1168-1172;

  6. Rivelli, M

    1. Phosphoramidon abolishes the increases in endothelin-1 release induced by ischemia-hypoxia in isolated perfused guinea pig lungs.
      S Vemulapalli, M Rivelli, P J Chiu, M del Prado and J A Hey
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1062-1069;

  7. Roblero, J S

    1. [N-methyl-Tyr1,N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat.
      S P Salas, J S Roblero, L F López, S Tachibana and J P Huidobro-Toro
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 979-986;

  8. Romeo, E

    1. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR).
      E Romeo, J Auta, A P Kozikowski, D Ma, V Papadopoulos, G Puia, E Costa and A Guidotti
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 971-978;

  9. Rosenthal, G J

    1. Thymocyte injury after in vitro chemical exposure: potential mechanisms for thymic atrophy.
      C E Comment, B L Blaylock, D R Germolec, P L Pollock, Y Kouchi, H W Brown, G J Rosenthal and M I Luster
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1267-1273;

S

  1. Salas, S P

    1. [N-methyl-Tyr1,N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat.
      S P Salas, J S Roblero, L F López, S Tachibana and J P Huidobro-Toro
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 979-986;

  2. Salituro, F G

    1. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
      B M Baron, B L Harrison, I A McDonald, B S Meldrum, M G Palfreyman, F G Salituro, B W Siegel, A L Slone, J P Turner and H S White
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 947-956;

  3. Sanwal, G G

    1. Characteristics of a cytosolic arylacylamidase metabolizing thiacetazone.
      P Khanna, S Kaur, G G Sanwal and B Ali
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1225-1231;

  4. Sargent, C A

    1. Effect of the phospholipase A2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat hearts.
      C A Sargent, O Vesterqvist, J R McCullough, M L Ogletree and G J Grover
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1161-1167;

  5. Schindler, C W

    1. Pathophysiological and pharmacological mechanisms of acute cocaine toxicity in conscious rats.
      S R Tella, G R Korupolu, C W Schindler and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 936-946;

  6. Segal, D S

    1. Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine.
      R Kuczenski and D S Segal
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1085-1094;

  7. Seth, P

    1. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle.
      E A Kowaluk, P Seth and H L Fung
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 916-922;

  8. Shenvi, A

    1. Nonadrenergic, noncholinergic contractile responses of the guinea pig hilar bronchus involve the preferential activation of tachykinin neurokinin2 receptors.
      L M Renzetti, A Shenvi and C K Buckner
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 957-963;

  9. Shin, S G

    1. Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.
      D R Sohn, K Kobayashi, K Chiba, K H Lee, S G Shin and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1195-1202;

  10. Shinnick-Gallagher, P

    1. Epileptogenesis reduces the sensitivity of presynaptic gamma-aminobutyric acidB receptors on glutamatergic afferents in the amygdala.
      E K Asprodini, D G Rainnie and P Shinnick-Gallagher
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1011-1021;

  11. Siegel, B W

    1. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
      B M Baron, B L Harrison, I A McDonald, B S Meldrum, M G Palfreyman, F G Salituro, B W Siegel, A L Slone, J P Turner and H S White
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 947-956;

  12. Simmons, T W

    1. L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine transport in rat liver canalicular membrane vesicles: potential reabsorption mechanisms for biliary metabolites of glutathione and its S-conjugates.
      T W Simmons, M W Anders and N Ballatori
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1182-1188;

  13. Slone, A L

    1. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
      B M Baron, B L Harrison, I A McDonald, B S Meldrum, M G Palfreyman, F G Salituro, B W Siegel, A L Slone, J P Turner and H S White
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 947-956;

  14. Smith, F L

    1. Evidence that endogenous opioids mediate the antinociceptive effects of intrathecally administered calcium in mice.
      F L Smith and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 995-1003;

  15. Snyder, D W

    1. Evidence that phospholipase A2 (PLA2) inhibitors can selectively block PLA2-mediated contractions of guinea pig lung pleural strips.
      D W Snyder, C D Sommers, J L Bobbitt and E D Mihelich
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1147-1153;

  16. Sohn, D R

    1. Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.
      D R Sohn, K Kobayashi, K Chiba, K H Lee, S G Shin and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1195-1202;

  17. Soltis, E E

    1. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
      L A Cassis, P E Rippetoe, E E Soltis, D J Painter, R Fitz and M N Gillespie
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1168-1172;

  18. Sommers, C D

    1. Evidence that phospholipase A2 (PLA2) inhibitors can selectively block PLA2-mediated contractions of guinea pig lung pleural strips.
      D W Snyder, C D Sommers, J L Bobbitt and E D Mihelich
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1147-1153;

  19. Sparks, M S

    1. Effect of chlorethylclonidine on arterial blood pressure and heart rate in the conscious rat.
      M T Piascik, M S Sparks and T A Pruitt
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 901-906;

  20. Szallasi, A

    1. Identification of alpha-1-acid glycoprotein (orosomucoid) as a major vanilloid binding protein in serum.
      A Szallasi, N E Lewin and P M Blumberg
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 883-888;

  21. Szeto, H H

    1. Central opioid modulation of breathing dynamics in the fetal lamb: effects of [D-Pen2,D-Pen5]-enkephalin and partial antagonism by naltrindole.
      P Y Cheng, D L Wu, J Decena, Y Cheng, S McCabe and H H Szeto
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1004-1010;

T

  1. Tachibana, S

    1. [N-methyl-Tyr1,N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat.
      S P Salas, J S Roblero, L F López, S Tachibana and J P Huidobro-Toro
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 979-986;

  2. Takanashi, M

    1. Concentration- and time-dependence of phosphoinositide hydrolysis induced by endothelin-1 in relation to the positive inotropic effect in the rabbit ventricular myocardium.
      M Takanashi and M Endoh
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1189-1194;

  3. Takasaki, K

    1. Purinergic vasoconstrictor component revealed by moderate cooling in the isolated mesenteric vasculature of Sprague-Dawley rats.
      R Yamamoto, K Takasaki and G A Nickols
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1133-1138;

  4. Takenaga, M

    1. Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance.
      R Igarashi, J Hoshino, M Takenaga, S Kawai, Y Morizawa, A Yasuda, M Otani and Y Mizushima
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1214-1219;

  5. Taylor, D G

    1. Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands.
      J A Keiser, F A Bjork, J C Hodges and D G Taylor
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1154-1160;

  6. Tella, S R

    1. Pathophysiological and pharmacological mechanisms of acute cocaine toxicity in conscious rats.
      S R Tella, G R Korupolu, C W Schindler and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 936-946;

  7. Teraoka, K

    1. Inhibition by amiloride of ouabain-evoked catecholamine secretion from cultured adrenal chromaffin cells: evidence for its blocking action on interaction between ouabain and Na+/K(+)-pump.
      K Morita, M Azuma, S Hamano, M Oka and K Teraoka
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1209-1213;

  8. Torres, O A

    1. Characterization and localization of leukotriene C4 receptors in bullfrog lung.
      M Chiono, J J Andazola, O A Torres and C A Herman
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1248-1255;

  9. Turner, J P

    1. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
      B M Baron, B L Harrison, I A McDonald, B S Meldrum, M G Palfreyman, F G Salituro, B W Siegel, A L Slone, J P Turner and H S White
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 947-956;

  10. Turner, N C

    1. Characterization of the antagonist activity of the PAF antagonists RP 59227 and WEB 2086 on elicited guinea pig peritoneal macrophages. Evidence for variable affinities and kinetics.
      N C Turner and L J Wood
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1139-1146;

U

  1. Urade, Y

    1. Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats.
      N Eguchi, T Kaneko, Y Urade, H Hayashi and O Hayaishi
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1110-1120;

V

  1. Vallée, E

    1. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
      E Vallée, E Azoulay-Dupuis, J Bauchet and J J Pocidalo
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1203-1208;

  2. Varon, S

    1. Receptor-mediated toxicity of norepinephrine on cultured catecholaminergic neurons of the rat brain stem.
      J C Louis, E Magal and S Varon
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1274-1283;

  3. Vemulapalli, S

    1. Phosphoramidon abolishes the increases in endothelin-1 release induced by ischemia-hypoxia in isolated perfused guinea pig lungs.
      S Vemulapalli, M Rivelli, P J Chiu, M del Prado and J A Hey
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1062-1069;

  4. Vesterqvist, O

    1. Effect of the phospholipase A2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat hearts.
      C A Sargent, O Vesterqvist, J R McCullough, M L Ogletree and G J Grover
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1161-1167;

W

  1. Wecker, L

    1. Dietary choline supplementation increases the density of nicotine binding sites in rat brain.
      J B Coutcher, G Cawley and L Wecker
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1128-1132;

  2. White, H S

    1. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
      B M Baron, B L Harrison, I A McDonald, B S Meldrum, M G Palfreyman, F G Salituro, B W Siegel, A L Slone, J P Turner and H S White
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 947-956;

  3. Wolgin, D L

    1. Effect of prior sensitization of stereotypy on the development of tolerance to amphetamine-induced hypophagia.
      D L Wolgin and G G Kinney
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1232-1241;

  4. Wood, L J

    1. Characterization of the antagonist activity of the PAF antagonists RP 59227 and WEB 2086 on elicited guinea pig peritoneal macrophages. Evidence for variable affinities and kinetics.
      N C Turner and L J Wood
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1139-1146;

  5. Woods, J H

    1. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
      S D Comer, T F Burke, J W Lewis and J H Woods
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1051-1056;

  6. Wu, D L

    1. Central opioid modulation of breathing dynamics in the fetal lamb: effects of [D-Pen2,D-Pen5]-enkephalin and partial antagonism by naltrindole.
      P Y Cheng, D L Wu, J Decena, Y Cheng, S McCabe and H H Szeto
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1004-1010;

Y

  1. Yamamoto, R

    1. Purinergic vasoconstrictor component revealed by moderate cooling in the isolated mesenteric vasculature of Sprague-Dawley rats.
      R Yamamoto, K Takasaki and G A Nickols
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1133-1138;

  2. Yasuda, A

    1. Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance.
      R Igarashi, J Hoshino, M Takenaga, S Kawai, Y Morizawa, A Yasuda, M Otani and Y Mizushima
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1214-1219;

Z

  1. Zalups, R K

    1. Shifts in the dose-effect relationship for the nephropathy induced by cadmium-metallothionein in rats after a reduction in renal mass.
      R K Zalups, R M Gelein and M G Cherian
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1256-1266;

  2. Zimányi, I

    1. Discrimination of multiple binding sites for antagonists of the calcium release channel complex of skeletal and cardiac sarcoplasmic reticulum.
      W M Mack, I Zimányi and I N Pessah
      Journal of Pharmacology and Experimental Therapeutics September 1992, 262 (3) 1028-1037;
Back to top

In this issue

Advertisement